ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 113497 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 113497; 2) Community: the network communities that were significantly associated with the response to NSC 113497; 3) Molecule: the relationships between components within communities and NSC 113497; 4) MDR: the compounds that were significantly associated with the NSC 113497.

NSC Compound Enrichment Correlation
NSC 643724 Null 0.0395466756030208 -0.14430233
NSC 685189 Null 0.0395466756030208 0.21946753
NSC 726195 2-phenyl 3-[(6-ethyl, 4-amino, 5-(4-chlorophenyl) pyrimidin-2-yl)] quinazolin-4-one 0.0395466756030208 0.10219518
NSC 736122 1-(Benzothien-3'-yl)-3,4-dihydronaphthalene-2-acrylic acid ethyl ester 0.0395466756030208 -0.088287239
NSC 752398 4-[5-(3,4-Dimethoxyphenyl)-2-(3,4,5-trimethoxybenzoyl)-3,4-dihydro-2H-pyrazol-3-yl]benzonitrile 0.0395466756030208 0.058035076
NSC 117281 ANTINEOPLASTIC-117281 0.0396077140933377 0.27885102
NSC 176324 5-Isoxazoleacetic acid, .alpha.-amino-3-chloro-4,5-dihydro-4-hydroxy-, (4R-(4.alpha.,5.beta.(S*)))- 0.0396077140933377 0.33619318
NSC 268993 Deferoxamine hydrochloride 0.0396077140933377 0.074530959
NSC 295642 Null 0.0396077140933377 0.18429578
NSC 364830 Camptothecin Derivative 0.0396077140933377 0.072914032
Total:72  Current:61    [First] [Prev] [Next] [Last]